QUIDELORTHO CORP (QDEL) Debt Components
- 2026-06-28: Long-term Debt, Current MaturitiesUSD $355.70M; Debt, CurrentUSD $355.70M; Long-term Debt and Lease ObligationUSD $2.54B; Long-term DebtUSD (m).
- 2026-03-29: Long-term Debt, Current MaturitiesUSD $228.20M; Debt, CurrentUSD $228.20M; Long-term Debt and Lease ObligationUSD $2.46B; Long-term DebtUSD (m).
- 2025-12-28: Long-term Debt, Current MaturitiesUSD $178.30M; Debt, CurrentUSD $178.30M; Long-term Debt and Lease ObligationUSD $2.47B; Long-term DebtUSD (m).
- 2025-12-28: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m); Long-term DebtUSD $2.70B.
QUIDELORTHO CORP Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Debt, Current USD | Long-term Debt and Lease Obligation USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $355.70M | $355.70M | $2.54B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.90M |
| 2026-03-29 | $228.20M | $228.20M | $2.46B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.00M |
| 2025-12-28 | $178.30M | $178.30M | $2.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.90M |
| 2025-12-28 | (m) | (m) | (m) | $2.70B | $178.30M | $76.30M | $77.20M | $54.00M | $934.50M | $1.38B | (m) |
| 2025-09-28 | $162.50M | $162.50M | $2.50B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $28.70M |
| 2025-06-29 | $534.20M | $534.20M | $2.07B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-30 | $393.80M | $393.80M | $2.11B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-29 | $341.80M | $341.80M | $2.14B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2024-12-29 | (m) | (m) | (m) | $2.49B | $341.80M | $173.50M | $1.97B | $0.00 | $0.00 | (m) | (m) |
| 2024-09-29 | $373.80M | $373.80M | $2.18B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $356.40M | $356.40M | $2.21B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $161.10M | $161.10M | $2.24B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $139.80M | $139.80M | $2.27B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $2.42B | $139.80M | $137.60M | $171.90M | $1.97B | $0.00 | (m) | (m) |
| 2023-10-01 | $193.00M | $193.00M | $2.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-07-02 | $207.40M | $207.40M | $2.52B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-04-02 | $207.50M | $207.50M | $2.59B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-01-01 | $207.50M | $207.50M | $2.43B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-01-01 | (m) | (m) | (m) | $2.65B | $207.50M | $172.70M | $137.50M | $137.50M | $1.99B | (m) | (m) |
| 2022-10-02 | $207.60M | $207.60M | $2.69B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-07-03 | $207.80M | $207.80M | $2.74B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-01-02 | $300.00K | $300.00K | $700.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |